Eupraxia Pharmaceuticals Inc. announced that its common shares have commenced trading on the Nasdaq Global Select Market, the highest tier of Nasdaq, after previously being listed on the Nasdaq Capital Market. The company will continue to trade under the ticker symbol "EPRX" on both Nasdaq and the Toronto Stock Exchange, with no action required by shareholders. Management will also participate in upcoming investor conferences, including the Cantor Global Healthcare Conference on September 11, the H.C. Wainwright 28th Annual Global Investment Conference on September 14, and the Morgan Stanley 24th Annual Global Healthcare Conference on September 15 and 16, all in New York. Chief Financial Officer Alex Rothwell said the graduation reflects the company's progress and growth as it advances its clinical programs.
Eupraxia Pharmaceuticals Inc. Common StockEupraxia's shares graduated to the Nasdaq Global Select Market, the highest tier, reflecting its progress and growth.
